Trial Profile
Bevacizumab for Radiation-induced necrosis of the brain
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Radiation injuries
- Focus Pharmacodynamics; Therapeutic Use
- 06 Nov 2015 New trial record